enzymes x AI = exozymes

The eXoZymes video library

Interviews, investor updates and the science behind cell-free biomanufacturing. Watch the platform that turns rare, unscalable chemistry into predictable production.

11 videos

Invizyne awarded $250K voucher from DoE
interview
Invizyne awarded $250K voucher from DoE December 04, 2024 · 131 views
Invizyne IPO comments by CEO Michael Heltzen
investors
Invizyne IPO comments by CEO Michael Heltzen November 11, 2024 · 438 views
Dr. Lalonde: From two years and 25 scientists to a few scientists for a few months
investors
Dr. Lalonde: From two years and 25 scientists to a few scientists for a few months August 08, 2024 · 124 views
Dr. Lalonde: Invizyne [...] helps the sustainability of this planet
investors
Dr. Lalonde: Invizyne [...] helps the sustainability of this planet August 08, 2024 · 260 views
NREL (DoE): What Invizyne is working on is a game changer
interview
NREL (DoE): What Invizyne is working on is a game changer August 02, 2024 · 172 views
Interview: NREL (DoE) working with Invizyne
interview
Interview: NREL (DoE) working with Invizyne August 02, 2024 · 223 views
Commercializing Invizyne’s cell-free platform - fireside chat
investors
Commercializing Invizyne’s cell-free platform - fireside chat July 30, 2024 · 203 views
Invizyne IPO - KOL Call with Dr. James J. Lalonde (July 17, 2024)
investors
Invizyne IPO - KOL Call with Dr. James J. Lalonde (July 17, 2024) July 22, 2024 · 233 views
Invizyne presented by Michael Heltzen & Tyler Korman
investors
Invizyne presented by Michael Heltzen & Tyler Korman July 01, 2024 · 784 views
Invizyne presented by Chris Marlett
investors
Invizyne presented by Chris Marlett June 13, 2024 · 338 views
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth
interview
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth May 22, 2024 · 1,279 views